XML 103 R91.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidating Financial Information Statement of Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2017
Dec. 31, 2016
Condensed Cash Flow Statements, Captions [Line Items]        
Net cash (used in) provided by operating activities $ 157,395 $ 75,296    
Capital expenditures (13,673) (14,634)    
Investments (28) 0    
Net proceeds from the sale of business 0 551,419    
Sale of partial interest of equity method investment 833 0    
Proceeds from sales of real estate and other assets 44 44,315    
Proceeds from the sale of investments 3,057 4,950    
Net cash (used in) provided by investing activities (9,767) 586,050    
Long-term borrowings 0 202,694    
Repayments of long-term debt 0 (584,245)    
Long-term debt issuance costs 0 (1,689)    
Payments of dividends (21,922) (520,849)    
Tax withholdings related to net share settlements of share-based awards (5,493) (7,053)    
Proceeds from stock option exercises 581 2,385    
Change in intercompany receivables and payables and intercompany contributions (1) 0 0 [1]    
Net cash used in financing activities (26,834) (908,757)    
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash 120,794 (247,411)    
Cash, cash equivalents and restricted cash, beginning of period (1) [2] 691,251 611,198 $ 611,198  
Cash, cash equivalents and restricted cash, end of period 812,045 363,787 691,251 [2]  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract]        
Cash and cash equivalents 795,438 346,221 673,685  
Restricted cash and cash equivalents 16,607 17,566 17,566 $ 17,566
Cash, cash equivalents and restricted cash, end of period 812,045 363,787 691,251 [2]  
Non-cash settlement of intercompany balances   54,000    
Eliminations        
Condensed Cash Flow Statements, Captions [Line Items]        
Net cash (used in) provided by operating activities 0 0    
Capital expenditures 0 0    
Investments 0      
Net proceeds from the sale of business   0    
Sale of partial interest of equity method investment 0      
Proceeds from sales of real estate and other assets 0 0    
Proceeds from the sale of investments 0 0    
Net cash (used in) provided by investing activities 0 0    
Long-term borrowings   0    
Repayments of long-term debt   0    
Long-term debt issuance costs   0    
Payments of dividends 0 0    
Tax withholdings related to net share settlements of share-based awards 0 0    
Proceeds from stock option exercises 0 0    
Change in intercompany receivables and payables and intercompany contributions (1) 0 0 [1]    
Net cash used in financing activities 0 0    
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash 0 0    
Cash, cash equivalents and restricted cash, beginning of period (1) 0 0 0  
Cash, cash equivalents and restricted cash, end of period 0 0 0  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract]        
Cash and cash equivalents 0 0 0  
Restricted cash and cash equivalents 0 0 0  
Cash, cash equivalents and restricted cash, end of period 0 0 0  
Parent (Tribune Media Company) | Reportable Legal Entities        
Condensed Cash Flow Statements, Captions [Line Items]        
Net cash (used in) provided by operating activities (43,982) (133,188)    
Capital expenditures (2,813) (1,413)    
Investments 0      
Net proceeds from the sale of business   571,749    
Sale of partial interest of equity method investment 0      
Proceeds from sales of real estate and other assets 0 0    
Proceeds from the sale of investments 0 4,950    
Net cash (used in) provided by investing activities (2,813) 575,286    
Long-term borrowings   202,694    
Repayments of long-term debt   (583,232)    
Long-term debt issuance costs   (1,689)    
Payments of dividends (21,922) (520,849)    
Tax withholdings related to net share settlements of share-based awards (5,493) (7,053)    
Proceeds from stock option exercises 581 2,385    
Change in intercompany receivables and payables and intercompany contributions (1) 193,972 233,965 [1]    
Net cash used in financing activities 167,138 (673,779)    
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash 120,343 (231,681)    
Cash, cash equivalents and restricted cash, beginning of period (1) 687,868 592,204 592,204  
Cash, cash equivalents and restricted cash, end of period 808,211 360,523 687,868  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract]        
Cash and cash equivalents 791,604 342,957 670,302  
Restricted cash and cash equivalents 16,607 17,566 17,566  
Cash, cash equivalents and restricted cash, end of period 808,211 360,523 687,868  
Guarantor Subsidiaries | Reportable Legal Entities        
Condensed Cash Flow Statements, Captions [Line Items]        
Net cash (used in) provided by operating activities 227,838 209,514    
Capital expenditures (10,836) (12,468)    
Investments (28)      
Net proceeds from the sale of business   (8,168)    
Sale of partial interest of equity method investment 833      
Proceeds from sales of real estate and other assets 44 44,315    
Proceeds from the sale of investments 3,057 0    
Net cash (used in) provided by investing activities (6,930) 23,679    
Long-term borrowings   0    
Repayments of long-term debt   0    
Long-term debt issuance costs   0    
Payments of dividends 0 0    
Tax withholdings related to net share settlements of share-based awards 0 0    
Proceeds from stock option exercises 0 0    
Change in intercompany receivables and payables and intercompany contributions (1) (221,276) (239,190) [1]    
Net cash used in financing activities (221,276) (239,190)    
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash (368) (5,997)    
Cash, cash equivalents and restricted cash, beginning of period (1) 1,501 7,378 7,378  
Cash, cash equivalents and restricted cash, end of period 1,133 1,381 1,501  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract]        
Cash and cash equivalents 1,133 1,381 1,501  
Restricted cash and cash equivalents 0 0 0  
Cash, cash equivalents and restricted cash, end of period 1,133 1,381 1,501  
Non-Guarantor Subsidiaries | Reportable Legal Entities        
Condensed Cash Flow Statements, Captions [Line Items]        
Net cash (used in) provided by operating activities (26,461) (1,030)    
Capital expenditures (24) (753)    
Investments 0      
Net proceeds from the sale of business   (12,162)    
Sale of partial interest of equity method investment 0      
Proceeds from sales of real estate and other assets 0 0    
Proceeds from the sale of investments 0 0    
Net cash (used in) provided by investing activities (24) (12,915)    
Long-term borrowings   0    
Repayments of long-term debt   (1,013)    
Long-term debt issuance costs   0    
Payments of dividends 0 0    
Tax withholdings related to net share settlements of share-based awards 0 0    
Proceeds from stock option exercises 0 0    
Change in intercompany receivables and payables and intercompany contributions (1) 27,304 5,225 [1]    
Net cash used in financing activities 27,304 4,212    
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash 819 (9,733)    
Cash, cash equivalents and restricted cash, beginning of period (1) 1,882 11,616 11,616  
Cash, cash equivalents and restricted cash, end of period 2,701 1,883 1,882  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract]        
Cash and cash equivalents 2,701 1,883 1,882  
Restricted cash and cash equivalents 0 0 0  
Cash, cash equivalents and restricted cash, end of period $ 2,701 $ 1,883 $ 1,882  
[1] (1)Excludes the impact of a $54 million non-cash settlement of intercompany balances upon dissolution of certain Guarantor subsidiaries.
[2] (1)Cash, cash equivalents and restricted cash at the beginning of the three months ended March 31, 2017 of $611 million are comprised of $595 million of cash, cash equivalents and restricted cash from continuing operations as reflected in the Company’s unaudited Condensed Consolidated Balance Sheets and $16 million of cash, cash equivalents and restricted cash reflected in current assets of discontinued operations.